Adirondack Research & Management’s Orthofix Medical OFIX Stock Holding History

Adirondack Research & Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-53,944	Closed	-$2.29M	–	109
2016 Q2	$2.29M	Sell	53,944 -94,825	-64%	-$4.12M	0.86%	49
2016 Q1	$6.18M	Sell	148,769 -7,817	-5%	-$306K	2.24%	8
2015 Q4	$6.14M	Hold	156,586	–	–	2.22%	7
2015 Q3	$5.29M	Hold	156,586	–	–	2.03%	11
2015 Q2	$5.19M	Sell	156,586 -7,000	-4%	-$241K	1.9%	17
2015 Q1	$5.87M	Hold	163,586	–	–	2.28%	9
2014 Q4	$4.92M	Hold	163,586	–	–	1.84%	16
2014 Q3	$5.07M	Hold	163,586	–	–	1.88%	14
2014 Q2	$5.93M	Hold	163,586	–	–	2%	8
2014 Q1	$4.93M	Buy	163,586 +15,917	+11%	+$367K	1.89%	9
2013 Q4	$3.37M	Buy	147,669 +42,041	+40%	+$879K	1.64%	22
2013 Q3	$2.19M	Buy	+105,628	New	+$2.56M	1.26%	35

Other funds holding OFIX

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Adirondack Research & Management's OFIX Position: Q3 2016 in Review

Adirondack Research & Management sold out of Orthofix Medical (OFIX) in Q3 2016, closing a stake of 53,944 shares — an estimated $2.29M sold.

Adirondack Research & Management first reported a position in OFIX in Q3 2013 and held it in 12 quarters. The position peaked at $6.18M in Q1 2016. 141 funds tracked by Wall St. Rank hold OFIX as of Q3 2016.

Adirondack Research & Management reported no remaining Orthofix Medical position as of Q3 2016 after selling out during the quarter.
Adirondack Research & Management sold 53,944 Orthofix Medical shares in Q3 2016, an estimated $2.29M.
Adirondack Research & Management first reported a position in Orthofix Medical in Q3 2013 and held it in 12 quarters.
Adirondack Research & Management's Orthofix Medical position peaked at $6.18M in Q1 2016.
141 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2016.

Based on Adirondack Research & Management's 13F filing for Q3 2016, filed 10 Nov 2016.